Leadless pacemakers offer a promising alternative to bypass the weaknesses of transvenous leads, though further research is required before safe and routine clinical use.
What are the current achievements, clinical indications, and future perspectives of leadless pacemaker technology?
Leadless pacemakers represent a disruptive technology that eliminates lead- and pocket-related complications, with ongoing innovations poised to expand their use to dual-chamber pacing and cardiac resynchronization therapy.
Despite the technological advances in pacemaker technology, the transvenous implanted leads are still considered the Achilles' heel of this rhythm-control therapy. The leadless permanent pacemaker system was developed as an option to bypass the weakness of the transvenous approach. Advances in battery technology and deep miniaturisation of electronics now offer the opportunity to implant the whole pacemaker system into the right ventricle. This review aims to provide a comprehensive report on the advent of leadless pacemakers, their clinical usefulness and the future perspectives of this disruptive and promising technology. Further research is required before some of these technologies are safely and routinely used in clinical practice.
Vouliotis et al. (Fri,) conducted a review in Pacemaker indication. Leadless pacemakers vs. Transvenous pacemakers was evaluated. Leadless pacemakers offer a promising alternative to bypass the weaknesses of transvenous leads, though further research is required before safe and routine clinical use.